The role of bronchoscopic management in post-
tuberculosis tracheobronchial
stenosis is not well defined. To investigate the role of bronchoscopic intervention, including
silicone stenting, in the management of post-
tuberculosis tracheobronchial
stenosis, the current retrospective study was conducted at a tertiary referral hospital. Under rigid bronchoscopy, 80 patients underwent ballooning,
neodymium-
yttrium aluminium garnet
laser resection and/or bougienation as first-line methods of airway dilatation between January 2000 and December 2003 inclusive, and were followed for a median of 41 months.
Silicone stents were required in 75 out of 80 (94%) patients to maintain airway patency. Bronchoscopic intervention provided immediate symptomatic relief and improved lung function in 88% of the patients. After airway stabilisation,
stents were removed successfully in 49 out of 75 (65%) patients at a median of 14 months post-insertion. Three patients out of 75 (4%) eventually underwent surgical management. Acute complications included: excessive
bleeding (n = 1);
pneumothorax (n = 5); and
pneumomediastinum without mortality (n = 2).
Stent-related late complications, such as migration (51%),
granuloma formation (49%), mucostasis (19%) and re-
stenosis (40%), were controllable during a median follow-up of 41 months. In conclusion, bronchoscopic intervention, including
silicone stenting, could be a useful and safe method for treating post-
tuberculosis tracheobronchial
stenosis.